A PYMNTS Company

Spain: Watchdog probes Merck over contraception prices

By  |  November 25, 2019

The antitrust regulator in Spain has accused Merck of working with other companies to hinder the entry of generic versions of a hormonal contraceptive, the latest effort by a European government to crack down on anti-competitive practices in the pharmaceutical industry.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In a statement issued the National Commission on Markets and Competition announced that it is pursuing sanctions against Merck Sharp & Dohme, its European affiliate, and MSD Human Health Holding, the European parent, for possibly delaying competitors from entering the market for a vaginal ring in Spain.

    Full Content: Stat News

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.